USC Schaeffer

Home to the Schaeffer Center for Health Policy & Economics / Schaeffer Fellows. Transforming policy through evidence-based research and engaged citizenship.

[USC Schaeffer @USCSchaeffer]

A Medicare policy providing coverage for promising treatments while more evidence is gathered has effectively created a two-tiered system for access to innovative medical technologies, new USC Schaeffer research shows. https://t.co/AjVsYMy75f

[USC Schaeffer @USCSchaeffer]

Water and food insecurity are often seen as separate issues. However, people who lack clean drinking water also tend to struggle with food access & safety, new USC Schaeffer research finds.

The findings underscore the need for coordinated global action. https://t.co/EzSoonDQLK

[Health Affairs @Health_Affairs]

Greater flexibility in cost-effectiveness thresholds used by health technology assessment bodies may appear manageable in isolation. But these shifts can reshape drug pricing far beyond national boundaries. | Forefront

William Padula | @USC

https://t.co/fpJ5UqfSnr

[USC Schaeffer @USCSchaeffer]

Insured patients with higher cost-sharing on generic drugs can usually get a better deal through the Mark Cuban Cost Plus Drug Company, finds new research co-authored by USC Schaeffer's Erin Trish.
https://t.co/Y1WqsztYp9

[USC Schaeffer @USCSchaeffer]

As #Alzheimers clinical trials target early, biomarker-defined stages of disease, eligibility depends on how reliably biomarkers can be assessed across populations.

New USC research on biomarker variability provides important nuance to this challenge.
https://t.co/4kHVyCLbTy

[USC Schaeffer @USCSchaeffer]

Traditional Medicare now spends $55B annually on medical care for beneficiaries with #dementia, with costs expected to grow as the population ages.

Our updated interactive data-viz makes it easy to explore how this spending has changed over two decades. https://t.co/4K6U7njLb6

[USC Schaeffer @USCSchaeffer]

USC Schaeffer’s Dima Qato discusses her pharmacy mapping tool, which reveals where access has collapsed and highlights how policymakers can combat pharmacy deserts.

Her interview with @Drug_Topics ⤵️
https://t.co/OC20cUEEXm

[USC Schaeffer @USCSchaeffer]

A deal to embed a Massachusetts health system’s clinics inside CVS is unlikely to boost primary care access while weakening price competition in important but hard-to-measure ways, USC Schaeffer's John Romley tells @medcitynews.
https://t.co/3NF3C2EIOB

[USC Schaeffer @USCSchaeffer]

Declining civic participation is a threat to democracies worldwide, warns former UK PM Gordon Brown.

As chair of USC Schaeffer’s new Center for Civic Society, he says a renewed commitment to building community is essential to bolstering democracy.
🔗https://t.co/nzU3ky4Nid

[USC Schaeffer @USCSchaeffer]

USC Schaeffer's Geoffrey Joyce in the @nytimes discusses research suggesting that statins and drugs treating hypertension can reduce dementia risk. https://t.co/GwTnxKPVJW

[USC Schaeffer @USCSchaeffer]

Mail-order pharmacy dispensing of mifepristone rose sharply after FDA lifted in-person requirements, now under Supreme Court review, USC Schaeffer researchers reported in @JAMA_current. https://t.co/geqpGK0FYQ

[USC Schaeffer @USCSchaeffer]

The structural divide between #MedicareAdvantage drug coverage and standalone #PartD plans is widening under IRA cost pressures, according to research from USC Schaeffer's Geoffrey Joyce. https://t.co/RY9X4PYtUr

[USC Schaeffer @USCSchaeffer]

A big obstacle to developing #Alzheimers treatments: slow & uneven trial recruitment.

The USC Clinical Trial Recruitment Lab convened leaders to share strategies that speed recruitment, strengthen trust & ensure representative enrollment.

Our report ⤵️ https://t.co/u6YIvnvvbQ

[USC Schaeffer @USCSchaeffer]

About 1 in 3 kids and teens use dietary supplements, despite limited evidence of their safety and effectiveness, USC Schaeffer’s Dima Mazen Qato finds in new research.
https://t.co/jZ5NCCnHeS

[USC Schaeffer @USCSchaeffer]

There are often long delays between FDA approval and Medicare coverage of new devices. The agencies' plan to speed reimbursement for some devices could expand access to new technologies, USC Schaeffer’s William Padula told @FT. https://t.co/pR7V03JopQ

[USC Schaeffer @USCSchaeffer]

"Most-favored nation" has some drugmakers weighing whether to skip parts of Europe entirely, @business reports. USC Schaeffer’s Darius Lakdawalla says companies face a stark calculation: launching a treatment in Europe could end up halving the U.S. price.
https://t.co/2Dwc7EH9VB

[USC Schaeffer @USCSchaeffer]

A value-based contracting approach proposed by USC Schaeffer offers a sustainable path to expanding Medicare access to GLP-1s.
https://t.co/OLOcP2P5dQ

[Health Affairs @Health_Affairs]

To evaluate trends in inpatient & outpatient hospital care and the evolving composition of patients’ out-of-pocket cost sharing, @USCSchaeffer's Erin Duffy & coauthors look at 2021–22 data to shed light on the financial pressures on patients & providers. https://t.co/2SMx2ALy2Y

[USC Schaeffer @USCSchaeffer]

Redesigning low-income neighborhoods may help reduce childhood obesity, a USC Schaeffer study suggests.

2 years into redevelopment of South LA’s Jordan Downs, obesity & overweigh rose 50% more slowly, kids were more active & they had fewer sugary drinks. https://t.co/RXo8bMrRdY

[USC Schaeffer @USCSchaeffer]

Women aren’t just at higher risk of developing dementia—they’re also more likely to be caregivers, often unpaid. Dementia cost estimates from USC Schaeffer, cited in @TIME, highlight the staggering financial impact.
https://t.co/WSDssZgCcH